Reviewed clinical summary · Source-linked · Educational use only

Do Diet Changes Improve Blood Sugar Without Weight Loss?

Clinical Bottom Line

A crossover trial finds a Palaeolithic and a diabetes diet give equal glycaemic control when weight is kept stable, suggesting food-group differences alone do not help. PICO summary and commentary.

Summary: In a crossover trial in type 2 diabetes where body weight was deliberately kept stable and diets matched for macronutrients and glycaemic load, a Palaeolithic diet and a standard diabetes diet produced no difference in HbA1c or fructosamine, suggesting food-group differences alone do not improve glycaemic control without weight loss.

PICO Summary

ElementDetail
Population14 adults with type 2 diabetes and increased waist circumference; random-order crossover, two 4-week periods with 6-week washout.
InterventionPalaeolithic diet excluding cereal grains, dairy, and legumes (fruit, vegetables, tubers, fish, shellfish, lean meat, nuts, eggs, olive oil); energy adjusted to keep weight stable.
ComparisonDiabetes diet including wholegrains, low-fat dairy, and legumes; matched for macronutrients and glycaemic load.
OutcomeNo difference between diets in HbA1c or fructosamine. Weight was kept stable and the diets were successfully matched for macronutrient composition and glycaemic load, though not for fibre. The authors conclude characteristic food-group differences do not, by themselves, affect glycaemic control.
RCT J Nutr Sci · 2025

Palaeolithic vs diabetes diet, weight-stable

RCT crossover · type 2 diabetes · 4 weeks

Trial design
14 adults, T2D Enrolled & assessed RANDOMISED crossover Palaeolithic diet No grains/dairy/legumes n = 14 Diabetes diet Grains, dairy, legumes n = 14 HbA1c and fructosamine (relative change)
Between-group effect (95% CI)
0 (no difference) -12 12 HbA1c (rel. change diff)+2Fructosamine (rel. change diff)-3 % relative change difference · ✓ = significant
HbA1c diff
+2%
95% CI -6 to 5
Fructosamine diff
-3%
95% CI -10 to 4
HbA1c p
0.80
Not significant
Fructosamine p
0.40
Not significant
⬡ Bottom Line

With weight held stable and diets matched for macronutrients and glycaemic load, the Palaeolithic and diabetes diets gave no difference in HbA1c or fructosamine. Food-group differences alone do not improve glycaemic control.

Expert Commentary

This is a clever mechanistic trial whose result is genuinely clarifying, and it must be reported as the negative finding it is rather than the positive one implied before. By holding body weight stable and matching the two diets for macronutrients and glycaemic load, the investigators isolated the question that usually gets confounded: do the characteristic food-group differences of a Palaeolithic versus a diabetes diet improve glycaemic control independent of weight loss? The answer was no, HbA1c and fructosamine did not differ between the diets. The honest interpretation is that much of the glycaemic benefit attributed to Palaeolithic-style eating in other studies probably operates through weight loss and the accompanying reduction in energy and carbohydrate, not through some special property of excluding grains, dairy, and legumes. The obvious limitations are the tiny sample of fourteen and the short four-week periods, and the diets were not matched for fibre. Can I use this with my patients? Yes, to temper dietary dogma. It supports telling patients that the key levers for glycaemic control are energy balance, weight, and overall carbohydrate quality, not adherence to a particular named diet, which lets me favour sustainable, individualised eating over restrictive food-group elimination.

References

Fontes-Villalba M, Fika-Hernando ML, Picazo Ó, et al. Randomised crossover controlled trial of dietary interventions for glycaemic control when body weight is kept stable. J Nutr Sci. 2025;14:e59. doi:10.1017/jns.2025.10028

Educational use: Hormone Insight is intended for healthcare professionals and learners. Interpret each summary alongside the primary source, local guidance, and patient-specific clinical judgement.

Subscribe now

Welcome to Hormone Insight. Our mission is to support clinical decision-making with accessible, evidence-based insights from recent studies and trials.

© 2024-2026 Hormone Insight. All rights reserved.